Literature DB >> 27983540

Plasma nitric oxide level is correlated with microvascular functions in the peripheral arterial disease.

Muzaffer Akkoca1, Suzan Emel Usanmaz2, Cuneyt Koksoy1, Ugur Bengisun1, Emine Demirel-Yilmaz2.   

Abstract

At present there is no widely accepted biomarker for monitoring of vascular functions. The purpose of this prospective study was to investigate the association of some blood biomarkers with vascular reactivity in patients with peripheral arterial diseases (PAD). A prospective evaluation was made of 3 groups comprising a control group of healthy individuals, and patients with PAD caused by either atherosclerosis or Buerger's disease. Microvascular perfusion was examined using laser Doppler imaging of cutaneous erythrocyte flux after iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP). The correlation of microvascular reactivity with endothelium-related biomarkers was assessed. ACh-induced and SNP-induced vasodilations were significantly diminished in the PAD groups. The plasma nitric oxide (NO) levels of PAD patients were significantly higher than those of the control group, but asymmetric dimethylarginine, total antioxidant capacity and hydrogen sulphide levels were similar. Plasma NO level was negatively correlated with ACh and SNP-stimulated microvascular flow increase, whereas a positive correlation was detected with blood glucose and glycated hemoglobin (HbA1c) levels in all groups. These results indicate that a high plasma level of NO in PAD patients is associated with diminished endothelium-dependent and independent flow increase in the microvascular bed. An excessive amount of NO-induced nitrosative stress in an inflammatory condition that might be a reason for vascular dysfunction should be taken into consideration in the diagnostic and therapeutic approaches to PAD.

Entities:  

Keywords:  Peripheral arterial disease; atherosclerosis; endothelial dysfunction; microcirculation; nitric oxide

Mesh:

Substances:

Year:  2017        PMID: 27983540     DOI: 10.3233/CH-16143

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  1 in total

Review 1.  Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.

Authors:  Tommaso Gori
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.